About this Research Topic
The National Paediatric Diabetes Audit (NPDA) outcomes have shown marked improvements in diabetes care in young people. However, there remains a significant variation in outcomes between units and in the care and outcomes of those belonging to ethnic minority groups, and those living in the most deprived and least deprived areas.
There have been a host of developments in Type 1 diabetes technologies and treatment modalities in recent years which have changed how diabetes is managed in children. Although most aspects of care have improved significantly in the paediatric world, healthcare inequalities exist still impede provision.
New technologies have been shown to improve HbA1C, particularly with the use of HCL systems, and data has shown that improved outcomes at the start of a patient’s journey have long-term implications for better prognosis.
Advances in therapeutic options in type 2 diabetes management have largely occurred in adult care with limited provision in paediatrics.
The incidence of Type 2 diabetes is also currently increasing exponentially in the under 20 years age group. Potential treatment modalities are limited in the paediatric cohort and more research is needed in this area.
The goal of this Research Topic is to bring together a collection of papers that individually and collectively share best practice and developments in the management of Paediatric Diabetes. In so doing, these insights will identify potential standards and changes required in the management of Paediatric diabetes (Type 1 and 2) and potential areas for research.
We welcome the submission of manuscripts including, but not limited to, the following topics:
1. Strategies to reduce health inequalities in diabetes care in the paediatric population.
2. Standards for care and achievability across different healthcare systems.
3. Novel treatments and management in Type 2 diabetes.
4. Prevention of progression of pre-diabetes and diabetes in Type 2 diabetes in children.
5. Offering choice in diabetes care which is effective and individualised.
6. Monitoring in Type 2 diabetes and pre-diabetes.
There have been a host of developments in Type 1 diabetes technologies and treatment modalities in recent years which have changed how diabetes is managed in children. Although most aspects of care have improved significantly in the paediatric world, healthcare inequalities exist still impede provision.
New technologies have been shown to improve HbA1C, particularly with the use of HCL systems, and data has shown that improved outcomes at the start of a patient’s journey have long-term implications for better prognosis.
Advances in therapeutic options in type 2 diabetes management have largely occurred in adult care with limited provision in paediatrics.
The incidence of Type 2 diabetes is also currently increasing exponentially in the under 20 years age group. Potential treatment modalities are limited in the paediatric cohort and more research is needed in this area.
The goal of this Research Topic is to bring together a collection of papers that individually and collectively share best practice and developments in the management of Paediatric Diabetes. In so doing, these insights will identify potential standards and changes required in the management of Paediatric diabetes (Type 1 and 2) and potential areas for research.
We welcome the submission of manuscripts including, but not limited to, the following topics:
1. Strategies to reduce health inequalities in diabetes care in the paediatric population.
2. Standards for care and achievability across different healthcare systems.
3. Novel treatments and management in Type 2 diabetes.
4. Prevention of progression of pre-diabetes and diabetes in Type 2 diabetes in children.
5. Offering choice in diabetes care which is effective and individualised.
6. Monitoring in Type 2 diabetes and pre-diabetes.
Keywords: Paediatric diabetes, Insulin, Closed loop hybrid systems, Outcomes, Glycosylated Haemoglobin A1C, type 1 diabetes, HbA1C, Type 2 diabetes, pre-diabetes
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
